Infectious Mononucleosis and Other Epstein-Barr Virus–Associated Diseases: Part 2

Chapter 22 Infectious Mononucleosis and Other Epstein-Barr Virus–Associated Diseases


Part 2



Carl Allen, Cliona M. Rooney, Stephen Gottschalk



image

Figure 22-1 EBV-LATENT GENE EXPRESSION AND IMMUNOGENICITY OF COMMON EBV-ASSOCIATED MALIGNANCIES.


EBNA, Epstein-Barr nuclear antigen; LP, leader protein. For an explanation of symbols, see Fig. 21-1. *Not all lymphomas are latency type III.



EBV-Associated Malignancies




















Only gold members can continue reading. Log In or Register to continue

Related posts:

Heme Biosynthesis and Its Disorders: Sideroblastic Anemia Default ThumbnailHematologic Manifestations of Cancer Acquired Disorders of Red Cell, White Cell, and Platelet Production Hematology in Aging Disorders of Phagocyte Function Inherited Forms of Bone Marrow Failure
Tags:
Jun 12, 2016 | Posted by in HEMATOLOGY | Comments Off on Infectious Mononucleosis and Other Epstein-Barr Virus–Associated Diseases: Part 2

Full access? Get Clinical Tree

 Get Clinical Tree app for offline access
Malignancy EBV Frequency
Hodgkin disease ≈40%
Non-Hodgkin lymphomas  
Burkitt lymphoma 20%-95%
Diffuse large B-cell lymphoma and CD30+ Ki-1+ anaplastic large cell lymphoma 10%-35%